{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:24:59Z","timestamp":1785270299751,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8J1111"],"award-info":[{"award-number":["CMRPG8J1111"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8J1111"],"award-info":[{"award-number":["CMRPG8J1111"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8J1111"],"award-info":[{"award-number":["CMRPG8J1111"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study tested the hypothesis that double overexpression of miR-19a and miR-20a (dOex-mIRs) in human induced pluripotent stem cell (iPS)-derived mesenchymal stem cells (MSCs) effectively preserved left ventricular ejection fraction (LVEF) in dilated cardiomyopathy (DCM) (i.e., induced by doxorubicin) rat.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and results<\/jats:title>\n                <jats:p>In vitro study was categorized into groups G1 (iPS-MSC), G2 (iPS-MSC<jats:sup>dOex-mIRs<\/jats:sup>), G3 (iPS-MSC + H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>\/100uM), and G4 (iPS-MSC<jats:sup>dOex-mIRs<\/jats:sup> + H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>\/100uM). The in vitro results showed the cell viability was significantly lower in G3 than in G1 and G2, and that was reversed in G4 but it showed no difference between G1\/G2 at time points of 6\u2009h\/24\u2009h\/48\u2009h, whereas the flow cytometry of intra-cellular\/mitochondrial oxidative stress (DCFA\/mitoSOX) and protein expressions of mitochondrial-damaged (cytosolic-cytochrome-C\/DRP1\/Cyclophilin-D), oxidative-stress (NOX-1\/NOX2), apoptotic (cleaved-caspase-3\/PARP), fibrotic (p-Smad3\/TGF-\u00df), and autophagic (ratio of LC3B-II\/LC3BI) biomarkers exhibited an opposite pattern of cell-proliferation rate (all <jats:italic>p<\/jats:italic>&lt;\u20090.001). Adult-male SD rats (<jats:italic>n<\/jats:italic>=32) were equally divided into groups 1 (sham-operated control), 2 (DCM), 3 (DCM + iPS-MSCs\/1.2 \u00d7 10<jats:sup>6<\/jats:sup> cells\/administered by post-28\u2009day\u2019s DCM induction), and 4 (DCM + iPS-MSC<jats:sup>dOex-mIRs<\/jats:sup>\/1.2 \u00d7 10<jats:sup>6<\/jats:sup> cells\/administered by post-28\u2009day\u2019s DCM induction) and euthanized by day 60 after DCM induction. LV myocardium protein expressions of oxidative-stress signaling (p22-phox\/NOX-1\/NOX-2\/ASK1\/p-MMK4,7\/p-JNK1,2\/p-cJUN), upstream (TLR-4\/MAL\/MyD88\/TRIF\/TRAM\/ TFRA6\/IKK<jats:sub>\u03b1\/\u00df<\/jats:sub>\/NF-\u03baB) and downstream (TNF-\u03b1\/IL-1\u00df\/MMP-9) inflammatory signalings, apoptotic (cleaved-PARP\/mitochondrial-Bax), fibrotic (Smad3\/TGF-\u00df), mitochondrial-damaged (cytosolic-cytochrome-C\/DRP1\/cyclophilin-D), and autophagic (beclin1\/Atg5) biomarkers were highest in group 2, lowest in group 1 and significantly lower in group 4 than in group 3, whereas the LVEF exhibited an opposite pattern of oxidative stress (all <jats:italic>p<\/jats:italic>&lt;\u20090.0001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>iPS-MSC<jats:sup>dOex-mIRs<\/jats:sup> therapy was superior to iPS-MSC therapy for preserving LV function in DCM rat.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-021-02440-4","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T13:02:46Z","timestamp":1624971766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Double overexpression of miR-19a and miR-20a in induced pluripotent stem cell-derived mesenchymal stem cells effectively preserves the left ventricular function in dilated cardiomyopathic rat"],"prefix":"10.1186","volume":"12","author":[{"given":"Jiunn-Jye","family":"Sheu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Tan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Hsun","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Y.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-Hung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Lin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6305-5717","authenticated-orcid":false,"given":"Hon-Kan","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"issue":"23","key":"2440_CR1","doi-asserted-by":"publisher","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","volume":"134","author":"B Bozkurt","year":"2016","unstructured":"Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016;134(23):e579\u2013646. https:\/\/doi.org\/10.1161\/CIR.0000000000000455.","journal-title":"Circulation"},{"issue":"2","key":"2440_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P Elliott","year":"2008","unstructured":"Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on myocardial and pericardial diseases. Eur Heart J. 2008;29(2):270\u20136. https:\/\/doi.org\/10.1093\/eurheartj\/ehm342.","journal-title":"Eur Heart J"},{"issue":"14","key":"2440_CR3","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807\u201316. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.174287.","journal-title":"Circulation"},{"issue":"15","key":"2440_CR4","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","volume":"342","author":"GM Felker","year":"2000","unstructured":"Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342(15):1077\u201384. https:\/\/doi.org\/10.1056\/NEJM200004133421502.","journal-title":"N Engl J Med"},{"issue":"7","key":"2440_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4070\/kcj.2011.41.7.363","volume":"41","author":"DJ Choi","year":"2011","unstructured":"Choi DJ, Han S, Jeon ES, Cho MC, Kim JJ, Yoo BS, et al. Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the korean heart failure registry. Korean Circ J. 2011;41(7):363\u201371. https:\/\/doi.org\/10.4070\/kcj.2011.41.7.363.","journal-title":"Korean Circ J"},{"issue":"3","key":"2440_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/0002-9149(81)90534-8","volume":"47","author":"V Fuster","year":"1981","unstructured":"Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981;47(3):525\u201331. https:\/\/doi.org\/10.1016\/0002-9149(81)90534-8.","journal-title":"Am J Cardiol"},{"issue":"3","key":"2440_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0167-5273(88)90104-0","volume":"21","author":"Y Juilliere","year":"1988","unstructured":"Juilliere Y, Danchin N, Briancon S, et al. Dilated cardiomyopathy: long-term follow-up and predictors of survival. Int J Cardiol. 1988;21(3):269\u201377. https:\/\/doi.org\/10.1016\/0167-5273(88)90104-0.","journal-title":"Int J Cardiol"},{"key":"2440_CR8","doi-asserted-by":"publisher","first-page":"424751","DOI":"10.1155\/2015\/424751","volume":"2015","author":"TL Lynch IV","year":"2015","unstructured":"Lynch TL IV, Sivaguru M, et al. Oxidative Stress in Dilated Cardiomyopathy Caused by MYBPC3 Mutation. Oxid Med Cell Longev. 2015;2015:424751.","journal-title":"Oxid Med Cell Longev"},{"key":"2440_CR9","doi-asserted-by":"publisher","unstructured":"Holzem KM, Gomez JF, Glukhov AV, et al. Reduced response to I blockade and altered hERG1a\/1b stoichiometry in human heart failure. J Mol Cell Cardiol. 2016;96:82\u201392. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.06.008.","DOI":"10.1016\/j.yjmcc.2015.06.008"},{"issue":"23","key":"2440_CR10","doi-asserted-by":"publisher","first-page":"7113","DOI":"10.1073\/pnas.1507821112","volume":"112","author":"T Hashimoto","year":"2015","unstructured":"Hashimoto T, Kass DA. Stressed hearts inflame the body (in a good way). Proc Natl Acad Sci USA. 2015;112(23):7113\u20134. https:\/\/doi.org\/10.1073\/pnas.1507821112.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2440_CR11","first-page":"e38","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Writing Group Members, Mozaffarian D, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133:e38\u2013360.","journal-title":"Circulation"},{"issue":"16","key":"2440_CR12","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey de Jr, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147\u2013239. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.019.","journal-title":"J Am Coll Cardiol"},{"issue":"01","key":"2440_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","volume":"3","author":"G Savarese","year":"2017","unstructured":"Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Card Fail Rev. 2017;3(01):7\u201311. https:\/\/doi.org\/10.15420\/cfr.2016:25:2.","journal-title":"Card Fail Rev"},{"issue":"1","key":"2440_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ahj.2003.07.021","volume":"147","author":"TM Koelling","year":"2004","unstructured":"Koelling TM, Chen RS, Lubwama RN, L'Italien GJ, Eagle KA. The expanding national burden of heart failure in the United States: the influence of heart failure in women. Am Heart J. 2004;147(1):74\u20138. https:\/\/doi.org\/10.1016\/j.ahj.2003.07.021.","journal-title":"Am Heart J"},{"issue":"6","key":"2440_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jchf.2019.02.015","volume":"7","author":"C Balmforth","year":"2019","unstructured":"Balmforth C, Simpson J, Shen L, Jhund PS, Lefkowitz M, Rizkala AR, et al. Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF. JACC Heart Fail. 2019;7(6):457\u201365. https:\/\/doi.org\/10.1016\/j.jchf.2019.02.015.","journal-title":"JACC Heart Fail"},{"issue":"6","key":"2440_CR16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4070\/kcj.2019.0136","volume":"49","author":"P Dewan","year":"2019","unstructured":"Dewan P, Docherty KF, McMurray JJV. Sacubitril\/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction. Korean Circ J. 2019;49(6):469\u201384. https:\/\/doi.org\/10.4070\/kcj.2019.0136.","journal-title":"Korean Circ J"},{"key":"2440_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/CIRCRESAHA.113.301720","volume":"114","author":"Ismahil MA, Hamid T, Bansal SS, et","year":"2014","unstructured":"Ismahil MA, Hamid T, Bansal SS, et al. Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis. Circ Res. 2014;114:266\u201382.","journal-title":"Circ Res"},{"key":"2440_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.yjmcc.2016.12.002","volume":"102","author":"TL Lynch 4th","year":"2017","unstructured":"Lynch TL 4th, Ismahil MA, Jegga AG, et al. Cardiac inflammation in genetic dilated cardiomyopathy caused by MYBPC3 mutation. J Mol Cell Cardiol. 2017;102:83\u20139. https:\/\/doi.org\/10.1016\/j.yjmcc.2016.12.002.","journal-title":"J Mol Cell Cardiol."},{"issue":"4","key":"2440_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10741-009-9140-3","volume":"15","author":"B Bozkurt","year":"2010","unstructured":"Bozkurt B, Mann DL, Deswal A. Biomarkers of inflammation in heart failure. Heart Fail Rev. 2010;15(4):331\u201341. https:\/\/doi.org\/10.1007\/s10741-009-9140-3.","journal-title":"Heart Fail Rev"},{"issue":"11","key":"2440_CR20","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","volume":"91","author":"DL Mann","year":"2002","unstructured":"Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. 2002;91(11):988\u201398. https:\/\/doi.org\/10.1161\/01.RES.0000043825.01705.1B.","journal-title":"Circ Res"},{"issue":"10","key":"2440_CR21","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1161\/CIRCULATIONAHA.108.802918","volume":"119","author":"T Hamid","year":"2009","unstructured":"Hamid T, Gu Y, Ortines RV, Bhattacharya C, Wang G, Xuan YT, et al. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation. Circulation. 2009;119(10):1386\u201397. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.802918.","journal-title":"Circulation"},{"issue":"20","key":"2440_CR22","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1056\/NEJMra0800239","volume":"358","author":"E Braunwald","year":"2008","unstructured":"Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008;358(20):2148\u201359. https:\/\/doi.org\/10.1056\/NEJMra0800239.","journal-title":"N Engl J Med"},{"key":"2440_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.yjmcc.2015.11.015","volume":"93","author":"M Hulsmans","year":"2015","unstructured":"Hulsmans M, Sam F, Nahrendorf M. Monocyte and macrophage contributions to cardiac remodeling. J Mol Cell Cardiol. 2015;93:149\u201355.","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"2440_CR24","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1159\/000365512","volume":"23","author":"M Karabacak","year":"2014","unstructured":"Karabacak M, Dogan A, Tayyar S, Bas HA. Oxidative Stress Status Increase in Patients with Nonischemic Heart Failure. Med Princ Pract. 2014;23(6):532\u20137. https:\/\/doi.org\/10.1159\/000365512.","journal-title":"Med Princ Pract"},{"issue":"5","key":"2440_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/hrt.65.5.245","volume":"65","author":"JJF Belch","year":"1991","unstructured":"Belch JJF, Bridges AB, Scott N, et al. Oxygen free radicals and congestive heart failure. Br Heart J. 1991;65(5):245\u20138. https:\/\/doi.org\/10.1136\/hrt.65.5.245.","journal-title":"Br Heart J."},{"issue":"11","key":"2440_CR26","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/eurheartj\/14.11.1493","volume":"14","author":"J McMurray","year":"1993","unstructured":"McMurray J, Chopra M, Abdullah I, et al. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J. 1993;14(11):1493\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/14.11.1493.","journal-title":"Eur Heart J"},{"issue":"9","key":"2440_CR27","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1161\/CIRCRESAHA.112.265660","volume":"111","author":"AM Walters","year":"2012","unstructured":"Walters AM, Porter GA Jr, Brookes PS. Mitochondria as a drug target in ischemic heart disease and cardiomyopathy. Circ Res. 2012;111(9):1222\u201336. https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.265660.","journal-title":"Circ Res"},{"issue":"4","key":"2440_CR28","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0008-6363(99)00419-8","volume":"45","author":"WC Stanley","year":"2000","unstructured":"Stanley WC, Hoppel CL. Mitochondrial dysfunction in heart failure: potential for therapeutic interventions? Cardiovasc Res. 2000;45(4):805\u20136. https:\/\/doi.org\/10.1016\/S0008-6363(99)00419-8.","journal-title":"Cardiovasc Res"},{"issue":"8","key":"2440_CR29","first-page":"4612","volume":"12","author":"H-K Yip","year":"2020","unstructured":"Yip H-K, Shao P-L, Wallace CG, Sheu JJ, Sung PH, Lee MS. Early intramyocardial implantation of exogenous mitochondria effectively preserved left ventricular function in doxorubicin-induced dilated cardiomyopathy rat. Am J Transl Res. 2020;12(8):4612\u201327.","journal-title":"Am J Transl Res"},{"key":"2440_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/scrt546","volume":"6","author":"GW Hu","year":"2015","unstructured":"Hu GW, Li Q, Niu X, et al. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice. Stem Cell Res Ther. 2015;6:10.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"2440_CR31","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/sctm.17-0305","volume":"7","author":"S Soontararak","year":"2018","unstructured":"Soontararak S, Chow L, Johnson V, Coy J, Wheat W, Regan D, et al. Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose-Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model. Stem Cells Transl Med. 2018;7(6):456\u201367. https:\/\/doi.org\/10.1002\/sctm.17-0305.","journal-title":"Stem Cells Transl Med."},{"key":"2440_CR32","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3389\/fimmu.2017.01991","volume":"8","author":"C Roux","year":"2018","unstructured":"Roux C, Saviane G, Pini J, Bela\u00efd N, Dhib G, Voha C, et al. Immunosuppressive Mesenchymal Stromal Cells Derived from Human-Induced Pluripotent Stem Cells Induce Human Regulatory T Cells In Vitro and In Vivo. Front Immunol. 2018;8:1991. https:\/\/doi.org\/10.3389\/fimmu.2017.01991.","journal-title":"Front Immunol."},{"issue":"61","key":"2440_CR33","doi-asserted-by":"publisher","first-page":"103640","DOI":"10.18632\/oncotarget.21760","volume":"8","author":"HJ Wu","year":"2017","unstructured":"Wu HJ, Yiu WH, Wong DWL, Li RX, Chan LYY, Leung JCK, et al. Human induced pluripotent stem cell-derived mesenchymal stem cells prevent adriamycin nephropathy in mice. Oncotarget. 2017;8(61):103640\u201356. https:\/\/doi.org\/10.18632\/oncotarget.21760.","journal-title":"Oncotarget"},{"issue":"1","key":"2440_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jcyt.2017.09.003","volume":"20","author":"M Shafa","year":"2018","unstructured":"Shafa M, Ionescu LI, Vadivel A, Collins JJP, Xu L, Zhong S, et al. Human induced pluripotent stem cell-derived lung progenitor and alveolar epithelial cells attenuate hyperoxia-induced lung injury. Cytotherapy. 2018;20(1):108\u201325. https:\/\/doi.org\/10.1016\/j.jcyt.2017.09.003.","journal-title":"Cytotherapy"},{"issue":"10","key":"2440_CR35","first-page":"3053","volume":"10","author":"SF Ko","year":"2018","unstructured":"Ko SF, Yen-Ta Chen YT, Wallace CG, et al. Inducible Pluripotent Stem Cell-Derived Mesenchymal Stem Cell Therapy Effectively Protected Kidney from Acute Ischemia-Reperfusion Injury. Am J Transl Res. 2018;10(10):3053\u201367.","journal-title":"Am J Transl Res"},{"issue":"11","key":"2440_CR36","doi-asserted-by":"publisher","first-page":"17750","DOI":"10.18632\/oncotarget.14831","volume":"8","author":"MS Lee","year":"2017","unstructured":"Lee MS, Lee FY, Chen YL, Sung PH, Chiang HJ, Chen KH, et al. Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial. Oncotarget. 2017;8(11):17750\u201362. https:\/\/doi.org\/10.18632\/oncotarget.14831.","journal-title":"Oncotarget"},{"key":"2440_CR37","doi-asserted-by":"crossref","unstructured":"Lee MS, Yip HK, Yang CC, el al. Overexpression of miR-19a and miR-20a in iPS-MSCs preserves renal function of chronic kidney disease with acute ischemia-reperfusion injury in rat. JCMM, 2021 (in press).","DOI":"10.1111\/jcmm.16613"},{"issue":"28","key":"2440_CR38","doi-asserted-by":"publisher","first-page":"45626","DOI":"10.18632\/oncotarget.17320","volume":"8","author":"FY Lee","year":"2017","unstructured":"Lee FY, Chen KH, Wallace CG, Sung PH, Sheu JJ, Chung SY, et al. Xenogeneic human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsis. Oncotarget. 2017;8(28):45626\u201342. https:\/\/doi.org\/10.18632\/oncotarget.17320.","journal-title":"Oncotarget"},{"issue":"2","key":"2440_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1536\/ihj.50.191","volume":"50","author":"P-H Sung","year":"2009","unstructured":"Sung P-H, Sun C-K, Sheung-Fat, et al. Impact of hyperglycemic control on left ventricular myocardium. A molecular and cellular basic study in a diabetic rat model. Int Heart J. 2009;50(2):191\u2013206. https:\/\/doi.org\/10.1536\/ihj.50.191.","journal-title":"Int Heart J"},{"issue":"10","key":"2440_CR40","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1097\/CCM.0000000000001138","volume":"43","author":"F-Y Lee","year":"2015","unstructured":"Lee F-Y, Chen Y-L, Sung P-H, Ma M-C, Pei S-N, Wu C-J, et al. Intracoronary Transfusion of Circulation-Derived CD34+ Cells Improves Left Ventricular Function in Patients With End-Stage Diffuse Coronary Artery Disease Unsuitable for Coronary Intervention. Crit Care Med. 2015;43(10):2117\u201332. https:\/\/doi.org\/10.1097\/CCM.0000000000001138.","journal-title":"Crit Care Med"},{"issue":"5","key":"2440_CR41","doi-asserted-by":"publisher","first-page":"e391","DOI":"10.1097\/CCM.0000000000004285","volume":"48","author":"H-K Yip","year":"2020","unstructured":"Yip H-K, Fang W-F, Li Y-C, Lee F-Y, Lee C-H, Pei S-N, et al. Human Umbilical Cord-Derived Mesenchymal Stem Cells for Acute Respiratory Distress Syndrome. Crit Care Med. 2020;48(5):e391\u20139. https:\/\/doi.org\/10.1097\/CCM.0000000000004285.","journal-title":"Crit Care Med"},{"issue":"4","key":"2440_CR42","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1097\/CCM.0b013e31819c0667","volume":"37","author":"C-K Sun","year":"2009","unstructured":"Sun C-K, Chang L-T, Sheu J-J, Chiang C-H, Lee F-Y, Wu C-J, et al. Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy. Crit Care Med. 2009;37(4):1197\u2013205. https:\/\/doi.org\/10.1097\/CCM.0b013e31819c0667.","journal-title":"Crit Care Med"},{"key":"2440_CR43","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/jpi.12357","volume":"61","author":"S Chua","year":"2016","unstructured":"Chua S, Lee F-Y, Chiang H-J, et al. The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome. J Pineal Res. 2016;61:438\u201356.","journal-title":"J Pineal Res"},{"key":"2440_CR44","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.biopha.2018.10.095","volume":"109","author":"C-C Yang","year":"2019","unstructured":"Yang C-C, Chen Y-T, Wallace CG, Chen K-H, Cheng B-C, Sung P-H, et al. Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat. Biomed Pharmacother. 2019;109:658\u201370. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.095.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2440_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5551\/jat.14316","volume":"20","author":"C-H Yang","year":"2013","unstructured":"Yang C-H, Sheu J-J, Tsai T-H, Chua S, Chang L-T, Chang H-W, et al. Effect of tacrolimus on myocardial infarction is associated with inflammation, ROS, MAP kinase and Akt pathways in mini-pigs. J Atheroscler Thromb. 2013;20(1):9\u201322. https:\/\/doi.org\/10.5551\/jat.14316.","journal-title":"J Atheroscler Thromb"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02440-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-021-02440-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02440-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T13:17:52Z","timestamp":1624972672000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02440-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2440"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02440-4","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"7 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Institute of Animal Care and Use Committee at Kaohsiung Chang Gung Memorial Hospital (Affidavit of Approval of Animal Use Protocol No. 2019061902) and performed in accordance with the Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have read the journal\u2019s policy on disclosure of potential conflicts of interest and the journal\u2019s authorship agreement. The authors declare that they have no conflicts of interest. The article has been reviewed by and approved by all named authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"371"}}